Scilex Holding Co. 8-K: Stock & Warrant Details

TL;DR

Scilex 8-K: Common stock par $0.00001, warrants exercise $4.0250.

AI Summary

Scilex Holding Company filed an 8-K on December 22, 2025, reporting information related to its common stock and warrants. The filing details the par value of its common stock as $0.00001 per share and the exercise price of its warrants to purchase common stock at $4.0250 per share.

Why It Matters

This filing provides specific details about Scilex's capital structure, which is important for investors to understand the terms of their equity and potential dilution.

Risk Assessment

Risk Level: low — This is a routine filing providing basic details about the company's stock and warrants, with no immediate financial or operational risks indicated.

Key Numbers

• $0.00001 — Common Stock Par Value (Represents the nominal value per share of Scilex's common stock.)
• $4.0250 — Warrant Exercise Price (The price at which holders can exercise their warrants to purchase one share of common stock.)

Key Players & Entities

• Scilex Holding Company (company) — Registrant
• 0001820190 (company) — Central Index Key
• 001-39852 (company) — SEC File Number
• $0.00001 (dollar_amount) — Par value of common stock
• $4.0250 (dollar_amount) — Exercise price of warrants

FAQ

Key Financial Figures

• $0.0001 — h registered) Common Stock, par value $0.0001 per share SCLX The Nasdaq Stock Mar
• $402.50 — mon stock, each at an exercise price of $402.50 SCLXW The Nasdaq Stock Market LLC
• $50 million — an aggregate principal amount of up to $50 million in one or more tranches (the "Loan").
• $22.6 m — egate principal amount of approximately $22.6 million, excluding the structure fee. T

Filing Documents

• sclx-20251222.htm (8-K) — 45KB
• 0001193125-25-328656.txt ( ) — 202KB
• sclx-20251222.xsd (EX-101.SCH) — 62KB
• sclx-20251222_htm.xml (XML) — 6KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure As previously disclosed, on December 1, 2025, Scilex Holding Company (the "Company") entered into a Non-Recourse Loan and Securities Pledge Agreement (the "Loan Agreement") with The St. James Bank & Trust Company Ltd., a corporation existing under the laws of the Bahamas (the "Lender"), pursuant to which the Lender agreed to loan the Company an aggregate principal amount of up to $50 million in one or more tranches (the "Loan"). On December 22, 2025, the first tranche of the Loan closed in the aggregate principal amount of approximately $22.6 million, excluding the structure fee. The information in Item 7.01 of this Current Report on Form 8-K is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference into any filing by the Company, under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCILEX HOLDING COMPANY By: /s/ Henry Ji Name: Henry Ji Date: December 22, 2025 Title: Chief Executive Officer & President 3

View Full Filing

View this 8-K filing on SEC EDGAR